Diligence memo · auto-generated · as of July 2, 2026
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Zimmer Biomet Holdings, Inc. operates in Other Health Care, based in Warsaw.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Zimmer Biomet Holdings, Inc. has raised $216M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $216M on 2023-02-06.
Most recent recorded round closed around 2023-02-06.
Valuation (modeled)modeled
Provath models Zimmer Biomet Holdings, Inc. at approximately $2.9B (range $1.2B–$4.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.50× the median modeled value of Series D+ Other Health Care companies in 2022–2024 (17 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 3.4 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: United Digestive Holdings, LLC, DispatchHealth Holdings, Inc., Main Street Rural, Inc., Richmond Buyer L.P., Thirty Madison, Inc..
Peoplefiled
18 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.